Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2020  |  Volume : 33  |  Issue : 2  |  Page : 452-457

Cystatin C and β2 microglobulin in preeclampsia: a prospective study


1 Departments of Obstetrics and Gynecology, Faculty of Medicine, Menoufia University, Menoufia, Egypt
2 Departments of Clinical Pathology, Faculty of Medicine, Menoufia University, Menoufia, Egypt
3 Department of Obstetrics and Gynecology, Suez Insurance Hospital, Suez, Egypt

Correspondence Address:
Mohamed S. A. Soliman
Suez Insurance Hospital, Suez
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/mmj.mmj_135_19

Rights and Permissions

Objective To study the plasma levels of β-2-microglobulin (β2M) and cystatin C in patients with preeclampsia. Background The plasma level of cystatin C has been reported to have a better diagnostic performance for diagnosing preeclampsia. Patients and methods A prospective case–control study was carried out on 20 women diagnosed as having preeclampsia as well as 20 pregnant healthy. All patients attended the Obstetrics and Gynecology Department and outpatient clinic of Menoufia University Hospital, Menoufia Governorate, and Suez Insurance Hospital, Suez Governorate, during the study period from December 2016 to November 2017. Full history, routine, physical examination, and other investigations were taken. Results Mean antepartum and postpartum serum cystatin C, mean antepartum and postpartum serum β2M, albuminuria, and creatinine were increased significantly in preeclamptic patient group than the normal pregnancy group. The mean serum level of cystatin C before delivery was 1.78 ± 0.58 and 1.19 ± 0.32, which reduced significantly to 1.31 ± 0.49 and 0.91 ± 0.18 after delivery among preeclamptic patient and normotensive pregnancy groups, respectively. The mean serum level of β2M before delivery was 2.49 ± 0.56 and 1.92 ± 0.64, which reduced significantly to 1.98 ± 0.43 and 1.58 ± 0.49 after delivery among preeclamptic patients and normotensive pregnancy group, respectively. Conclusion Maternal serum cystatin C and β2M concentrations were significantly higher in preeclampsia compared with the normotensives. Cystatin C and β2M can be used as significant and independent predictive factors affecting the occurrence of preeclampsia.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed9    
    Printed0    
    Emailed0    
    PDF Downloaded6    
    Comments [Add]    

Recommend this journal